Complementary and alternative medicine during cancer treatment: beyond innocence.
about
Music interventions for psychological and physical outcomes in cancer: a systematic review and meta-analysis.A musculoskeletal model of low grade connective tissue inflammation in patients with thyroid associated ophthalmopathy (TAO): the WOMED concept of lateral tension and its general implications in disease.Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1Nurse and patient characteristics predict communication about complementary and alternative medicine.Apigenin and its impact on gastrointestinal cancers.Potential therapeutic role of Tridham in human hepatocellular carcinoma cell line through induction of p53 independent apoptosisHypochondriacal attitudes and beliefs, attitudes towards complementary and alternative medicine and modern health worries predict patient satisfaction.Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures.Classification of CAM use and its correlates in patients with early-stage breast cancer.Herb-drug pharmacokinetic interaction of a traditional chinese medicine jia-wei-xiao-yao-san with 5-Fluorouracil in the blood and brain of rat using microdialysis.In vivo antitumor potential of Ipomoea pes-caprae on melanoma cancer.Use of complementary and alternative medicine by patients with hematological diseases experience at a university hospital in northeast MexicoPrevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugsInvestigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer.In silico identification of anti-cancer compounds and plants from traditional Chinese medicine database.Effects of acupuncture for cancer pain and quality of life - a case series.A multisite, community oncology-based randomized trial of a brief educational intervention to increase communication regarding complementary and alternative medicineAdverse Drug Reactions and Expected Effects to Therapy with Subcutaneous Mistletoe Extracts (Viscum album L.) in Cancer PatientsNatural products for chemopreventive and adjunctive therapy in oncologic disease.Integrative oncology for the whole person: a multidimensional approach to cancer care.Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method.Drug interactions with phytotherapeutics in oncology.Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.Oral antineoplastic agent interactions with medicinal plants and food: an issue to take into account.Induction of apoptosis in A431 skin cancer cells by Cissus quadrangularis Linn stem extract by altering Bax-Bcl-2 ratio, release of cytochrome c from mitochondria and PARP cleavage.Chemotherapeutic effects of bioassay-guided extracts of the American cockroach, Periplaneta americana.Intratumoral Mistletoe (Viscum album L) Therapy in Patients With Unresectable Pancreas Carcinoma: A Retrospective Analysis.Communication predictors and consequences of Complementary and Alternative Medicine (CAM) discussions in oncology visitsEvaluation of a Patient CAM-with-Chemotherapy Educational Brochure.Use of complementary and alternative medicine by patients with cancer in northern Turkey: analysis of cost and satisfaction.The Herb-Drug Pharmacokinetic Interaction of 5-Fluorouracil and Its Metabolite 5-Fluoro-5,6-Dihydrouracil with a Traditional Chinese Medicine in Rats.Trends in botanical dietary supplement use among US adults by cancer status: The National Health and Nutrition Examination Survey, 1999 to 2014.Complementary and alternative medicine use by patients receiving curative-intent chemotherapy.Belief in complementary and alternative medicine is related to age and paranormal beliefs in adults.The effect of complementary and alternative medicines on CYP3A4-mediated metabolism of three different substrates: 7-benzyloxy-4-trifluoromethyl-coumarin, midazolam and docetaxel.The in-vitro effect of complementary and alternative medicines on cytochrome P450 2C9 activity.Factors associated with the use of complementary and alternative medicines for prostate cancer by long-term survivors.The Use of a Brochure to Enable CAM-with-Chemotherapy Patient Education.Evaluating medicinal plants for anticancer activity.
P2860
Q30422144-9DB49B33-C119-49A7-9D9C-BAEF31524C94Q30830185-3D15D3C9-40A7-49C7-8DD7-601C648D2243Q33639024-523DB3C4-795A-4001-AC5A-329802CBE425Q33803022-9A3B12BF-AC6F-4CE7-827E-6B40CBA382F6Q34314564-5FC966FA-69F1-4E08-B3E2-462BCE4F8341Q34464794-0E20856B-4020-4EF7-8E46-597E2B8A7FC8Q34497187-1B2C7549-46CB-4EA2-BABA-490A4CA6C2C2Q34722389-25E15104-CFAE-4B74-8E3C-847969109201Q35078582-7705C50E-7B79-4A27-9EF4-4BF8970DB585Q35226944-F0F7BACE-207E-4620-95A4-B3BD9F4DCE01Q35228658-CAA33617-CFB3-469C-9C82-A0D0DC5A9A8AQ36283131-E3508291-254D-4009-964C-7903A19AD0F7Q36746739-C2D1B9D7-D1EC-4458-905A-24A3D5DA4FEFQ36762928-DCF26646-BECA-4153-A043-9679698DFDADQ36870882-66055F01-FBCC-4538-96CD-3923317F2966Q37071902-014287B3-CD97-4CB9-8224-CB0EB0242D95Q37265375-DAE4DA98-4D47-4302-A065-9F81E94EA139Q37594584-FC3D04DD-8AB5-4737-A439-CA0D34EA65F9Q37617207-985D91F8-A002-417E-A324-5A67BFAD4FFFQ37691081-067B5D9D-8182-4A28-BA94-21A67BD3355AQ37846001-4C09E2F3-F190-4728-9C1B-22C1CE4FAABEQ38175476-9F1BD145-F2BF-4A52-A8EA-2EEB7A7DD97DQ38335110-65F7B1EE-2BE1-4525-B7BA-1AED4C56811EQ38868735-5A29A8C9-D3C3-4ACF-8980-01F84922F851Q39240468-AF7A873E-8594-4286-9707-00BBFEBE1ADEQ39511688-7045BE4B-F1D6-4614-A1F1-483827C5269DQ40223950-AEDBFE58-3CDE-4CC8-A6BC-9C582AD9A63AQ40989291-77F3B5A8-1E91-49BF-A4E0-ABD759BE8933Q43179854-DF1D5F58-5A45-4CBF-AECC-1071DE482220Q44452616-580C6BC9-C888-4E82-B6D7-8F04D32F1720Q47204428-E18F066F-2003-4415-BE6D-C4D171504163Q47358362-1BAFC52F-5B58-46AC-9BAF-449A45FC69C0Q47438382-F3D91F34-30C5-4529-8897-D7CAFD2659B3Q47582817-437B3E71-2279-47DA-B1E5-C94D1E54E622Q47928719-60BC3EFA-DB5E-4EA7-A50C-5AAA384423C2Q50457694-88E9F63B-E81E-4B64-9C75-C173612F8F95Q52669421-760CE445-3C61-4F56-8FEB-C4C46C01D194Q53086914-C1C9A959-DB0F-4C5C-9377-E70EAB8EC7E6Q53669931-4D6F7107-3742-4095-8514-BA03F69FCFA9
P2860
Complementary and alternative medicine during cancer treatment: beyond innocence.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Complementary and alternative medicine during cancer treatment: beyond innocence.
@ast
Complementary and alternative medicine during cancer treatment: beyond innocence.
@en
type
label
Complementary and alternative medicine during cancer treatment: beyond innocence.
@ast
Complementary and alternative medicine during cancer treatment: beyond innocence.
@en
prefLabel
Complementary and alternative medicine during cancer treatment: beyond innocence.
@ast
Complementary and alternative medicine during cancer treatment: beyond innocence.
@en
P2093
P1433
P1476
Complementary and alternative medicine during cancer treatment: beyond innocence.
@en
P2093
Floris A de Jong
Jaap Verweij
Metin Tascilar
Ron H J Mathijssen
P304
P356
10.1634/THEONCOLOGIST.11-7-732
P577
2006-07-01T00:00:00Z